Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-004621-24Phase 3Completed
Phase 3 trial of glycerol in atopic dermatitis (AD), sponsored by Pierre Fabre Laboratories. Primary endpoint: Percentage of patients with at least one flare over 12 weeks. Started Nov 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-004621-24.